IRCT2015111724799N3
Completed
Phase 2
A clinical trial to evaluate the effect of inhaled pharmaceutical Penthrox (Methoxyflurane) compared with the placebo group on pain in patients with limb fracture
Vice chancellor for research, Baqiyatallah University of Medical Sciences0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Condition 1: Sequelae of fracture of arm. Condition 2: Sequelae of other fractures of lower limb.
- Sponsor
- Vice chancellor for research, Baqiyatallah University of Medical Sciences
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients older than 18 years who have had limb fractures.
- •Exclusion criteria: Patients with a history of allergy to inhaled medications, severe injuries, including a ruptured liver and the kidneys, liver disease, kidney disease, patient dissatisfaction and age under 18 and over 80 years as well as patients with a decreased level of consciousness
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A RANDOMIZED DOUBLE BLIND ACTIVE CONTROLLED PARALLEL TRIAL TO COMPARE THE EFFECT OF INHALATION OF COOLER AIR(OF DIFFERENT TEMPERATURES 18-22°c,23-27°c AND 28-30°c)WITH WARMER AIR(33-37°c)ON SYMPTOMS AND LUNG FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA OF MILD SEVERITYCTRI/2009/091/000701MITTAL HOSPITA150
Completed
Not Applicable
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)COPD and sPAHJPRN-UMIN000002080Tohoku University20
Recruiting
Phase 3
Investigating the effect of lavender on reducing endoscopic anxietyanxiety.IRCT20230729058960N1Sabzevar University of Medical Sciences90
Completed
Not Applicable
Inhalation of heated, humidified air (rhinothermy) in the common cold: a feasibility studyCommon coldInfection - Other infectious diseasesACTRN12616000470493Fisher & Paykel Healthcare30
Active, not recruiting
Phase 1
Trial to test the safety, half-life, and antiviral efficacy of a new drug (human antibody) called DZIF-10c (administered inhalatively) in healthy volunteers and SARS-CoV-2-infected participantsSARS-CoV-2 infection (only mild to moderate disease)MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-004448-27-DEniversity of Cologne96